INLIF Current Ratio 1971-1970 | INLF
INLIF current ratio from 1971 to 1970. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| INLIF Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.016B | $0.016B |
| INLIF LIMITED is a company engaged in the research, development, manufacturing and sales of injection molding machine-dedicated manipulator arms. INLIF LIMITED is based in Quanzhou, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.627B | 26.81 |
| Boston Scientific (BSX) | United States | $152.250B | 36.31 |
| Stryker (SYK) | United States | $144.004B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $135.646B | 0.00 |
| Medtronic (MDT) | Ireland | $118.875B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.688B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.538B | 24.28 |
| ResMed (RMD) | United States | $41.629B | 29.77 |
| GE HealthCare Technologies (GEHC) | United States | $33.329B | 15.66 |
| Agilent Technologies (A) | United States | $32.420B | 21.14 |
| Terumo (TRUMY) | Japan | $27.464B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $25.691B | 16.99 |
| Insulet (PODD) | United States | $21.458B | 71.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.814B | 12.61 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.750B | 0.00 |
| Baxter (BAX) | United States | $12.050B | 9.31 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.159B | 26.30 |
| Lantheus Holdings (LNTH) | United States | $3.812B | 10.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.350B | 23.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.144B | 13.95 |
| Perrigo (PRGO) | Ireland | $3.030B | 7.57 |
| ICU Medical (ICUI) | United States | $2.669B | 18.17 |
| Haemonetics (HAE) | United States | $2.528B | 11.28 |
| LeMaitre Vascular (LMAT) | United States | $2.097B | 44.96 |
| Curaleaf Holdings (CURLF) | Canada | $1.850B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.800B | 77.27 |
| AtriCure (ATRC) | United States | $1.764B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.605B | 10.10 |
| AdaptHealth (AHCO) | United States | $1.259B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.157B | 14.79 |
| Acuren (TIC) | United States | $1.119B | 0.00 |
| Neogen (NEOG) | United States | $1.110B | 17.62 |
| BioLife Solutions (BLFS) | United States | $1.072B | 2237.00 |
| Tilray Brands (TLRY) | Canada | $1.012B | 0.00 |
| InMode (INMD) | Israel | $0.872B | 8.07 |
| Kestra Medical Technologies (KMTS) | United States | $0.752B | 0.00 |
| Valneva SE (VALN) | France | $0.723B | 0.00 |
| Surmodics (SRDX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| SNDL (SNDL) | Canada | $0.528B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.405B | 13.96 |
| Evolus (EOLS) | United States | $0.373B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Owens & Minor (OMI) | United States | $0.358B | 3.17 |
| Capricor Therapeutics (CAPR) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.283B | 21.44 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.251B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.230B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Organigram Global (OGI) | Canada | $0.220B | 0.00 |
| Quanterix (QTRX) | United States | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| Jushi Holdings (JUSHF) | United States | $0.157B | 0.00 |
| Biote (BTMD) | United States | $0.154B | 4.62 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.07 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.16 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.084B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 37.42 |
| Zynex (ZYXI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.02 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |